For example, previous studies have shown that Cx43 expression was significantly decreased in gastric cancer, melanoma cancer [15], pancreatic cancer [16,17], lung cancer [18,19], chronic B-cell leukemia [20], prostate cancer [21], breast cancer [22,23,24,25], and thyroid cancer [9]. This evidence concerns the gene GJA1 and prostate cancer.